Literature DB >> 20125164

miR-122 continues to blaze the trail for microRNA therapeutics.

Dirk Haussecker1, Mark A Kay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20125164      PMCID： PMC2839286          DOI： 10.1038/mt.2009.313

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  14 in total

1.  Silencing of microRNAs in vivo with 'antagomirs'.

Authors:  Jan Krützfeldt; Nikolaus Rajewsky; Ravi Braich; Kallanthottathil G Rajeev; Thomas Tuschl; Muthiah Manoharan; Markus Stoffel
Journal:  Nature       Date:  2005-10-30       Impact factor: 49.962

2.  Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA.

Authors:  Catherine L Jopling; Minkyung Yi; Alissa M Lancaster; Stanley M Lemon; Peter Sarnow
Journal:  Science       Date:  2005-09-02       Impact factor: 47.728

3.  miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1.

Authors:  Jinhong Chang; Emmanuelle Nicolas; Debora Marks; Chris Sander; Anthony Lerro; Marie Annick Buendia; Chunxiao Xu; William S Mason; Thomas Moloshok; Roque Bort; Kenneth S Zaret; John M Taylor
Journal:  RNA Biol       Date:  2004-07-01       Impact factor: 4.652

4.  Identification of tissue-specific microRNAs from mouse.

Authors:  Mariana Lagos-Quintana; Reinhard Rauhut; Abdullah Yalcin; Jutta Meyer; Winfried Lendeckel; Thomas Tuschl
Journal:  Curr Biol       Date:  2002-04-30       Impact factor: 10.834

5.  Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids.

Authors:  Sharookh B Kapadia; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

Review 6.  Therapeutic application of RNA interference for hepatitis C virus.

Authors:  Tsunamasa Watanabe; Takuya Umehara; Michinori Kohara
Journal:  Adv Drug Deliv Rev       Date:  2007-08-11       Impact factor: 15.470

7.  Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation.

Authors:  Jin Ye; Chunfu Wang; Rhea Sumpter; Michael S Brown; Joseph L Goldstein; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

8.  Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee model.

Authors:  Chih-Ming Chen; Yupeng He; Liangjun Lu; Hock Ben Lim; Rakesh L Tripathi; Tim Middleton; Lisa E Hernandez; David W A Beno; Michelle A Long; Warren M Kati; Todd D Bosse; Daniel P Larson; Rolf Wagner; Robert E Lanford; William E Kohlbrenner; Dale J Kempf; Tami J Pilot-Matias; Akhteruzzaman Molla
Journal:  Antimicrob Agents Chemother       Date:  2007-10-01       Impact factor: 5.191

9.  MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.

Authors:  Shoumei Bai; Mohd W Nasser; Bo Wang; Shu-Hao Hsu; Jharna Datta; Huban Kutay; Arti Yadav; Gerard Nuovo; Pawan Kumar; Kalpana Ghoshal
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

Review 10.  Predicting the therapeutic response in patients with chronic hepatitis C: the role of viral kinetic studies.

Authors:  Peter Ferenci
Journal:  J Antimicrob Chemother       Date:  2003-11-25       Impact factor: 5.790
View more
  15 in total

Review 1.  All's well that transcribes well: non-coding RNAs and post-stroke brain damage.

Authors:  Raghu Vemuganti
Journal:  Neurochem Int       Date:  2013-08-15       Impact factor: 3.921

Review 2.  Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation.

Authors:  Brandi N Davis-Dusenbery; Connie Wu; Akiko Hata
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

3.  Resolving Subcellular miRNA Trafficking and Turnover at Single-Molecule Resolution.

Authors:  Sethuramasundaram Pitchiaya; Laurie A Heinicke; Jun I Park; Elizabeth L Cameron; Nils G Walter
Journal:  Cell Rep       Date:  2017-04-18       Impact factor: 9.423

Review 4.  Complexity of microRNA function and the role of isomiRs in lipid homeostasis.

Authors:  Kasey C Vickers; Praveen Sethupathy; Jeanette Baran-Gale; Alan T Remaley
Journal:  J Lipid Res       Date:  2013-03-15       Impact factor: 5.922

5.  Suberoylanilide hydroxamic acid inhibits growth of head and neck cancer cell lines by reactivation of tumor suppressor microRNAs.

Authors:  Jharna Datta; Mozaffarul Islam; Samidha Dutta; Sounak Roy; Quintin Pan; Theodoros N Teknos
Journal:  Oral Oncol       Date:  2016-03-19       Impact factor: 5.337

Review 6.  Outside the coding genome, mammalian microRNAs confer structural and functional complexity.

Authors:  Virginie Olive; Alex C Minella; Lin He
Journal:  Sci Signal       Date:  2015-03-17       Impact factor: 8.192

7.  RNA-binding protein IGF2BP2/IMP2 is required for laminin-β2 mRNA translation and is modulated by glucose concentration.

Authors:  Valerie Schaeffer; Kim M Hansen; David R Morris; Renée C LeBoeuf; Christine K Abrass
Journal:  Am J Physiol Renal Physiol       Date:  2012-04-18

Review 8.  Functions of microRNAs in cardiovascular biology and disease.

Authors:  Akiko Hata
Journal:  Annu Rev Physiol       Date:  2012-11-13       Impact factor: 19.318

9.  Heterogeneous Ribonucleoprotein K (hnRNP K) Binds miR-122, a Mature Liver-Specific MicroRNA Required for Hepatitis C Virus Replication.

Authors:  Baochang Fan; F X Reymond Sutandy; Guan-Da Syu; Stefani Middleton; Guanghui Yi; Kuan-Yi Lu; Chien-Sheng Chen; C Cheng Kao
Journal:  Mol Cell Proteomics       Date:  2015-09-01       Impact factor: 5.911

10.  RNA regulation of the immune system.

Authors:  K Mark Ansel
Journal:  Immunol Rev       Date:  2013-05       Impact factor: 12.988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.